173 related articles for article (PubMed ID: 26780925)
1. Bacterial profile and bone healing in rats receiving cancer therapeutic doses of bisphosphonates and corticosteroids: a pilot study.
Jabbour Z; do Nascimento C; El-Hakim M; Henderson JE; de Albuquerque Junior RF
Int J Oral Maxillofac Surg; 2016 Sep; 45(9):1162-9. PubMed ID: 26780925
[TBL] [Abstract][Full Text] [Related]
2. Bony changes in the jaws of rats treated with zoledronic acid and dexamethasone before dental extractions mimic bisphosphonate-related osteonecrosis in cancer patients.
Sonis ST; Watkins BA; Lyng GD; Lerman MA; Anderson KC
Oral Oncol; 2009 Feb; 45(2):164-72. PubMed ID: 18715819
[TBL] [Abstract][Full Text] [Related]
3. Teriparatide and the treatment of bisphosphonate-related osteonecrosis of the jaw: a rat model.
Ersan N; van Ruijven LJ; Bronckers AL; Olgaç V; Ilgüy D; Everts V
Dentomaxillofac Radiol; 2014; 43(1):20130144. PubMed ID: 24170800
[TBL] [Abstract][Full Text] [Related]
4. Impact of Actinomyces naeslundii on bisphosphonate-related osteonecrosis of the jaws in ovariectomized rats with periodontitis.
Li CL; Seneviratne CJ; Huo L; Lu WW; Zheng LW
J Craniomaxillofac Surg; 2015 Oct; 43(8):1662-9. PubMed ID: 26293192
[TBL] [Abstract][Full Text] [Related]
5. Effects of metformin on the prevention of bisphosphonate-related osteonecrosis of the jaw-like lesions in rats.
Nakagawa T; Tsuka S; Aonuma F; Nodai T; Munemasa T; Tamura A; Mukaibo T; Kondo Y; Masaki C; Hosokawa R
J Prosthodont Res; 2021 Jun; 65(2):219-224. PubMed ID: 32938854
[TBL] [Abstract][Full Text] [Related]
6. Effect of anti-angiogenesis induced by chemotherapeutic monotherapy, chemotherapeutic/bisphosphonate combination therapy and anti-VEGFA mAb therapy on tooth extraction socket healing in mice.
Akita Y; Kuroshima S; Nakajima K; Hayano H; Kanai R; Sasaki M; Sawase T
J Bone Miner Metab; 2018 Sep; 36(5):547-559. PubMed ID: 29043461
[TBL] [Abstract][Full Text] [Related]
7. Bisphosphonates inhibit bone remodeling in the jaw bones of rats and delay healing following tooth extractions.
Jabbour Z; El-Hakim M; Henderson JE; de Albuquerque RF
Oral Oncol; 2014 May; 50(5):485-90. PubMed ID: 24630257
[TBL] [Abstract][Full Text] [Related]
8. Perioperative discontinuation of intravenous bisphosphonate therapy reduces the incidence and severity of bisphosphonate-related osteonecrosis of the jaw: A randomized, controlled, prospective experimental study in rats.
Zandi M; Dehghan A; Ghadermazi K; Malekzadeh H; Akbarzadeh M
J Craniomaxillofac Surg; 2015 Nov; 43(9):1823-8. PubMed ID: 26355024
[TBL] [Abstract][Full Text] [Related]
9. Effects of dexamethasone and nimesulide on bisphosphonate-related osteonecrosis of the jaw: An experimental study.
Oliveira CC; Barros Silva PG; Ferreira AEC; Gonçalves RP; Sousa FB; Mota MRL; Alves APNN
Arch Oral Biol; 2017 Nov; 83():317-326. PubMed ID: 28869827
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of bisphosphonate-related osteonecrosis of the jaw-like lesions is increased in a chemotherapeutic dose-dependent manner in mice.
Kuroshima S; Sasaki M; Nakajima K; Tamaki S; Hayano H; Sawase T
Bone; 2018 Jul; 112():177-186. PubMed ID: 29729428
[TBL] [Abstract][Full Text] [Related]
11. Zoledronic acid - related osteonecrosis of the jaws. Experimental model with dental extractions in rats.
Barba-Recreo P; Del Castillo Pardo de Vera JL; García-Arranz M; Yébenes L; Burgueño M
J Craniomaxillofac Surg; 2014 Sep; 42(6):744-50. PubMed ID: 24342733
[TBL] [Abstract][Full Text] [Related]
12. The effects of icariin on wound healing of extraction sites with administration of zoledronic and dexamethasone: A rat model study.
Liu J; Mattheos N; Su C; Deng C; Luo N; Wang Z; Tang H
J Oral Pathol Med; 2018 Feb; 47(2):198-205. PubMed ID: 29130610
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinase-9 expression in alveolar extraction sockets of Zoledronic acid-treated rats.
Basi DL; Hughes PJ; Thumbigere-Math V; Sabino M; Mariash A; Lunos SA; Jensen E; Gopalakrishnan R
J Oral Maxillofac Surg; 2011 Nov; 69(11):2698-707. PubMed ID: 21752506
[TBL] [Abstract][Full Text] [Related]
14. Zoledronic acid delays wound healing of the tooth extraction socket, inhibits oral epithelial cell migration, and promotes proliferation and adhesion to hydroxyapatite of oral bacteria, without causing osteonecrosis of the jaw, in mice.
Kobayashi Y; Hiraga T; Ueda A; Wang L; Matsumoto-Nakano M; Hata K; Yatani H; Yoneda T
J Bone Miner Metab; 2010 Mar; 28(2):165-75. PubMed ID: 19882100
[TBL] [Abstract][Full Text] [Related]
15. Absence of exposed bone following dental extraction in beagle dogs treated with 9 months of high-dose zoledronic acid combined with dexamethasone.
Allen MR; Chu TM; Ruggiero SL
J Oral Maxillofac Surg; 2013 Jun; 71(6):1017-26. PubMed ID: 23375897
[TBL] [Abstract][Full Text] [Related]
16. Bone mineralization and vascularization in bisphosphonate-related osteonecrosis of the jaw: an experimental study in the rat.
Kün-Darbois JD; Libouban H; Mabilleau G; Pascaretti-Grizon F; Chappard D
Clin Oral Investig; 2018 Dec; 22(9):2997-3006. PubMed ID: 29453497
[TBL] [Abstract][Full Text] [Related]
17. Long-term oral bisphosphonates delay healing after tooth extraction: a single institutional prospective study.
Shudo A; Kishimoto H; Takaoka K; Noguchi K
Osteoporos Int; 2018 Oct; 29(10):2315-2321. PubMed ID: 29967931
[TBL] [Abstract][Full Text] [Related]
18. Dental extraction following zoledronate, induces osteonecrosis in rat's jaw.
Vidal-Gutiérrez X; Gómez-Clavel JF; Gaitán-Cepeda LA
Med Oral Patol Oral Cir Bucal; 2017 Mar; 22(2):e177-e184. PubMed ID: 28160593
[TBL] [Abstract][Full Text] [Related]
19. Local RANKL delivery improves socket healing in bisphosphonate treated rats.
Soundia A; Hadaya D; Chau Y; Gkouveris I; Bezouglaia O; Dry S; Pirih F; Aghaloo T; Tetradis S
Bone; 2021 Jul; 148():115945. PubMed ID: 33836308
[TBL] [Abstract][Full Text] [Related]
20. Prevention of tooth extraction-triggered bisphosphonate-related osteonecrosis of the jaws with basic fibroblast growth factor: An experimental study in rats.
Imada M; Yagyuu T; Ueyama Y; Maeda M; Yamamoto K; Kurokawa S; Jo JI; Tabata Y; Tanaka Y; Kirita T
PLoS One; 2019; 14(2):e0211928. PubMed ID: 30735554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
